美央创新科技完成数亿元Pre-A+轮融资，推动AI医疗机器人与医疗智能硬件创新

Core Viewpoint - Meiyang Innovation Technology has completed a multi-hundred million yuan Pre-A+ round of financing, which will be used to accelerate clinical registration, core technology iteration, and market expansion [2] Group 1: Company Overview - Meiyang is an AI-driven medical robotics and intelligent hardware innovation company, focusing on skin and shallow soft tissue treatment [5][6] - The company aims to create a scalable, traceable, and verifiable medical-grade intelligent hardware product matrix and service system [5] Group 2: Technology and Innovation - Meiyang's intelligent platform integrates high-precision imaging, multi-modal AI analysis, and precise injection capabilities, achieving a leap in non-invasive treatment precision and efficiency [3][4] - The company has developed a smart closed-loop platform that includes intelligent imaging diagnosis, energy source generator design, and AI deep learning technologies [6][9] Group 3: Market Position and Strategy - The company is positioned to leverage the rapid growth window for AI-driven medical-grade intelligent hardware, driven by the "Healthy China" strategy and the push for domestic medical device innovation [5][10] - Meiyang's strategy aligns with national policies promoting AI algorithm innovation and high-precision surgical robots, which will accelerate its technology transfer and market expansion [10][12] Group 4: Team and Expertise - The founding team consists of experts from various fields, including clinical medicine, aerospace, precision instrument design, and AI, with over 15 years of experience [5][6] - The team has established long-term collaborations with domestic and international clinical and industrial partners, ensuring a solid foundation for clinical demand definition and reproducible engineering methodologies [5][6]